Financhill
Back

Atlanta Braves Holdings Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
30

BATRA
Atlanta Braves Holdings

Last Price:
$39.13
Seasonality Move:
-0.82%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
30
Atlanta Braves Holdings (BATRA) is a Sell

Is Atlanta Braves Holdings a Buy, Sell or Hold?

  • The current Atlanta Braves Holdings [BATRA] share price is $39.76. The Score for BATRA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BATRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BATRA Stock Price Chart

What is Atlanta Braves Holdings's stock price today?

  • The Atlanta Braves Holdings share price today is $39.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BATRA is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

BATRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 35.63 Sell
Chaikin Money Flow: -5495 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.17 - 41.75) Sell
Bollinger Bands (100): (41.1 - 44.22) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

BATRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.25 Sell
20-day SMA: 40.69 Sell
50-day SMA: 41.7 Sell
200-day SMA: 42.5 Sell
8-day EMA: 40.2 Sell
20-day EMA: 40.66 Sell
50-day EMA: 41.46 Sell
200-day EMA: 42.29 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

Atlanta Braves Holdings Earnings Growth & BATRA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Atlanta Braves Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):